Fact CheckerSign in

NCT04130646Completed

Noninvasive VNS to Facilitate Excitability in Motor Cortex

Combining Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Transcranial Magnetic Stimulation (TMS) to Enhance Cortical Excitability

Source: ClinicalTrials.gov · Last updated 20 Apr 2025

Brief summary (registry, in English)

Transcranial Magnetic Stimulation (TMS) positively influences motor rehabilitation in stroke recovery. Transcutaneous auricular vagus nerve stimulation (taVNS) has shown effects on cortical plasticity. We investigate whether combination of TMS and taVNS is more effective at motor cortex excitability than either modality alone.

Status (registry)
Completed
Study type
Interventional
Enrollment
12 (actual)
First submitted
30 Sept 2019
Start date
Mar 2020
Primary completion date
Jun 2023
Lead sponsor
Medical University of South Carolina
Diseases
Stroke
NCT number
NCT04130646

What you commit to

  • Study type: Interventional
  • Participants enrolled: 12
  • From Mar 2020 to the primary completion date, Jun 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • currently taking seizure reducing medications
  • currently taking psychotropic medications
  • any psychotropic medication taken within 5 half-lives of procedure time
  • abuse or dependence of drugs (excluding nicotine and caffeine)
  • currently taking medications that lower the seizure threshold
  • taking any of the stimulants, thyroid medication, or steroids

Other illness

  • active psychiatric or neurological disorders
  • history of CNS disease, concussion, overnight hospitalization, or other neurologic sequelae, tumors, seizures, frequent or severe headaches
  • history of seizure or seizure disorder

Age

  • Pregnant females and children under the age of 18 will be excluded for safety reasons

Other

  • no TMS-induced motor cortex excitability changes in response to 20Hz motor cortex rTMS
  • metal implanted above the neck
  • implanted devices/ferrous metal of any kind
  • inability to determine motor threshold.
  • No vulnerable populations or special classes of subjects will be considered for participation.

Who the study is looking for

  • Age 18-80
  • endorsing good health

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of South Carolina
Coordinator of this site? Confirm its status
CharlestonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.